Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 781-790 of 1760 for

Edit search filters
  1. 3D Ultrasound Imaging For Breast Cancer Diagnosis

    Rochester, MN

  2. A Study for Cerebral Open Flow Microperfusion

    Rochester, MN

  3. A Safety To Evaluate The Safety And Effectiveness Of Pressurized Intraperitoneal Aerosolized Chemotherapy In Ovarian, Uterine, Colorectal, And Gastric Cancer Patients

    Jacksonville, FL

  4. MC200404, Safety And Immunogenicity Of PolyPEPI1018 Vaccine In The Treatment Of Late-stage Metastatic Colorectal Cancer

    Rochester, MN

  5. PH 1 Study To Evaluate Safety And Tolerability Of XmAb14045 In Patients With CD123-expressing Hematologic Malignancies

    Jacksonville, FL

  6. A Study To Evaluate Pembrolizumab Combined With Intensive Chemotherapy To Treat Patients With Acute Myeloid Leukemia

    Jacksonville, FL

  7. A Study To Evaluate Regional Radiotherapy In Biomarker Low-Risk Node Positive Breast Cancer

    Jacksonville, FL

  8. A Study Of Tucatinib Or Placebo With Trastuzumab And Pertuzumab For Metastatic HER2+ Breast Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. A Study To Evaluate AL102 To Treat Patients With Progressing Desmoid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. Niraparib In Combination With Trastuzumab In Metastatic HER2+ Breast Cancer

    Rochester, MN

.

Mayo Clinic Footer